A Multicenter Clinical Study on the Continuous vs. Intermittent Infusion of Ceftazidime-Avibactam in Critically Ill Patients With Severe Infections

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The objective of this study is to determine whether continuous infusion of ceftazidime-avibactam (CAZ-AVI) could improve clinical outcomes in critically ill patients compared with intermittent infusion.
Epistemonikos ID: 2219f038a7efa4ff786ec547fd94378f2507eaa0
First added on: Apr 24, 2025